Both elevated leptin and resistin concentrations was associated with the promotion of cancer stem cell survival and the promotion of invasion and migration via epithelial to mesenchymal transition in breast cancer cells (55, 56, 58), which contributes to the development of treatment resistance. This evidence concerns the gene LEP and breast carcinoma.